Interleukin-4 - CISMeF

Preferred Label : Interleukin-4;

MeSH definition : A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells.;

MeSH synonym : b-cell proliferating factor; mcgf-2; il4; il-4; b cell proliferating factor; b-cell stimulating factor-1; b-cell growth factor-1; b cell stimulatory factor 1; mast cell growth factor-2; mast cell growth factor 2; b cell stimulating factor 1; b cell growth factor 1; b-cell growth factor-i; b cell growth factor i; b-cell stimulatory factor 1; b-cell stimulatory factor-1; bcgf-1; binetrakin; bsf-1; b cell stimulatory factor-1; interleukin 4;

Registry Number MeSH : 207137-56-2;

MeSH annotation : DF: IL 4 or IL4;

Wikipedia link : https://en.wikipedia.org/wiki/Interleukin 4;

Is substance : O;

Details

Origin ID

D015847;

UMLS CUI

C0021758;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- B-cell growth factor [OMIM Phenotype]
- Interleukin 4 [LOINC component]
- Interleukin-4 [FMA entity]
- Interleukin-4 [NCIt concept]
- Interleukin-4 (substance) [SNOMED CT concept]
- interleukin-4 [SNOMED Notion]
Indexing information
- deacetylravidomycin M [MeSH Supplementary Concept]
- pitrakinra [MeSH Supplementary Concept]
Pharmacological action(s)
- adjuvants, immunologic [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
- antirheumatic agents [MeSH Descriptor]
Record concept(s)
- Interleukin-4 [MeSH concept]
Related MeSH Supplementary Concept(s)
- DAB(389)-interleukin 4 [MeSH Supplementary Concept]
- IL-4-PE40 protein, recombinant [MeSH Supplementary Concept]
- IL4 protein, human [MeSH Supplementary Concept]
- IL4-IL10 fusion protein [MeSH Supplementary Concept]
- Il4 protein, mouse [MeSH Supplementary Concept]
- Ph8 peptide [MeSH Supplementary Concept]
- diphtheria toxin-related-murine interleukin-4-fusion toxin [MeSH Supplementary Concept]
- interleukin 4 (1-129)-PE38KDEL [MeSH Supplementary Concept]
- interleukin 4 (38-37)-PE38KDEL [MeSH Supplementary Concept]
- interleukin-4 variant [MeSH Supplementary Concept]
- interleukin-4-Pseudomonas exotoxin [MeSH Supplementary Concept]
- pitrakinra [MeSH Supplementary Concept]
See also
- histocompatibility antigens class ii [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
UMLS correspondences (same concept)
- Interleukin 4 [LOINC component]
- Interleukin-4 [FMA entity]
- Interleukin-4 (substance) [SNOMED CT concept]
- interleukin-4 [SNOMED Notion]
Validated automatic mappings to BTNT
- Binetrakin [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients